Member Login Area
Member Icon Login
Member Login
Member Icon Close

Brochure / Flyer

Brochure
Flyer
Veeda Brochure
01. DCGI REQUIREMENTS TO CONDUCT BIOAVAILABILITY/BIOEQUIVALENCE (BA/BE) STUDIES IN INDIA.
02. DCGI REQUIREMENTS TO CONDUCT CLINICAL TRIALS IN INDIA.
03. Veeda’s experience with NMPA studies
05. Large Molecule Capabilities & Experience
06. Veeda Patient Based Clinical Trials Experience
07. Psychiatry Trials Capabilities of Veeda
08. Glucose Clamp Study Capabilities of Veeda
09. Veeda Biosimilar Capabilities
10. Veeda's expertise in handling Inhalation studies
11. Pharmacovigilance Services
12. Oncology Trials Capabilities of Veeda
13. Veeda Clinical Research Experience & Capabilites
Veeda Flyer
01. Determination of Free doxorubicin and Liposomal doxorubicin in human plasma by LC-MS/MS method.
02. A Novel Approach for Quantitation of Total Iron and Transferrin Bound Iron in Human serum samples by using

Inductively Coupled Plasma Optical Emission Spectroscopy (ICP-OES)
03. A Novel Approach for Quantitation of Total Iron and Transferrin Bound Iron in Human serum samples by using

Inductively Coupled Plasma Optical Emission Spectroscopy (ICP-OES)
04. Veeda Completes 20th Patient Based Pharmacokinetic Study Sucessully
05. VEEDA CRO deliberated a talk on Study Design Considerations of Bioequivalence Studies

in the workshop organized by CDSCO – New Delhi
06. ASSOCHAM Pharma Excellence Awards 2018 privileged Veeda Clinical Research with

"BEST CLINICAL RESEARCH 2018 "award
07. Renal Cell Carcinoma PK studies
File Size : 302 KB
Last Update : 28 Nov 2014
File Information : Patient based PK studies in Renal Cell Carcinoma.
08. Ophthalmology Pharmacokinetic studies
File Size : 316 KB
Last Update : 28 Nov 2014
File Information : Pharmacokinetic studies for ophthalmic products in aqueous humor of eye.
09. Topical Products Clinical Endpoint studies
File Size : 163 KB
Last Update : 28 Nov 2014
File Information : BE studies with clinical end-points for topical products in different patient population.
10. Long Acting Anti-Psychotic Injections
File Size : 336 KB
Last Update : 28 Nov 2014
File Information : Long acting antipsychotic injection in psychiatric population.
11. Liposomal Doxorubicin PK studies
File Size : 339 KB
Last Update : 28 Nov 2014
File Information : Liposomal Doxorubicin Injection PK studies for bioequivalence
15. Outlook-towards-Indian-CROs
16. NCE Bio analysis Capabilities
19. Simplifying the patient-based clinical trials processes for improved outcome
22. Long acting injectable Anti-psychotics
23. USFDA-Data Integrity Inspection
25. Protein bound nano particles
27. Training of Drug inspectors by CDSCO
28. USFDA - BioResearch Monitoring Program
29. Special Studies Capabilities like patch studies
30. Bioanalytical methods for Challenging molecules

Our exemplary regulatory track record

USFDA
33 times
Brazil ANVISA
7 times
WHO
5 times
UK MHRA
3 times
EU - AGES
1 times
South Africa - MCC
1 times
NPRA - Malaysia
4 times
DCGI
13 times